Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Chemotherapy For Pancreatic Cancer Strengthened By Vitamin A

XTALKS VITALS NEWS

Chemotherapy

Gemcitabine chemotherapy was paired with vitamin A, and the researchers noted both a reduction in cancer cell proliferation and invasion of surrounding tissue.

Share this!

May 26, 2016 | by Sarah Massey, M.Sc.

By combining chemotherapy and vitamin A, researchers have successfully reduced pancreatic cancer cell proliferation Tweet: Combining #chemotherapy and vitamin A reduced #pancreaticcancer proliferation http://ctt.ec/8ofYw+. Pancreatic cancer is one of the deadliest forms of the disease, with a survival rate of just 3 percent.

Traditional cancer treatment strategies – including chemotherapy and radiotherapy – are relatively ineffective against pancreatic cancer. While surgery has a higher success rate at removing the tumor tissue, the cancer has most often already metastasized by the time a diagnosis is made.

To develop a new approach to pancreatic cancer treatment, researchers at QMUL's Barts Cancer Institute focused on a new drug target: stromal cells. Up to 80 percent of pancreatic cancer tissue is made up of stromal cells, which surround and communicate with the cancer cells. These relatively-normal cells have a major impact on the progression of the pancreatic tumor, making them a key target for new cancer therapies.

Using both cell cultures and mice models, the researchers tested a combined therapy targeting both the cancerous tissue, and the surrounding stromal cells. Gemcitabine chemotherapy was paired with vitamin A, and the researchers noted both a reduction in cancer cell proliferation and invasion of surrounding tissue.

“This is the first time that we have combined vitamin A with chemotherapy for pancreatic cancer,” said Professor Hemant Kocher from QMUL's Barts Cancer Institute. “The results are so promising that we're now taking this into a clinical trial.”



By targeting both cell types, the researchers believe that multiple cell signaling pathways used by cancer cells to spread, could be interrupted. If the cancer cells are unable to communicate with the surrounding stromal cells, the tumor is unable to grow as aggressively as it would in the absence of treatment.

“Pancreatic cancer is extremely hard to treat by chemotherapy, so this finding is important because vitamin A targets the non-cancerous tissue and makes the existing chemotherapy more effective, killing the cancer cells and shrinking tumors,” said Kocher. “This could potentially be applicable to other cancers because if we try to understand the cancer as a whole, including its surrounding tissue, we may be able to develop new and better treatments.”

As a result of the preclinical studies, the researchers have now launched a clinical trial, STARPAC, to test the effectiveness of the combination therapy in patients. The trial – led by Barts Cancer Institute's Centre for Experimental Cancer Medicine – is currently recruiting participants.

“The majority of experimental work was done as part of my PhD project, and I am excited that our hard work in the laboratory is now being tested in the form of a clinical trial,” said QMUL PhD student Elisabete Carapuça. “We hope that it will benefit patients facing this awful disease.”


Keywords: Pancreatic Cancer, Clinical Trial, Combination Therapy


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Approach Could Allow Red Blood Cells to be Manufactured

March 27, 2017 - UK researchers at the University of Bristol have developed an immortal line of early adult erythroblasts capable of continuously producing mature red blood cells.

Featured In: Biotech News


Lung Cancer Recurrence Could Be Better Detected Using Biomarker Blood Test

March 24, 2017 - The results of a recent prospective clinical trial found that a biomarker blood test could detect lung cancer recurrence a full six months before imaging methods could spot the disease.

Featured In: Biotech News


Use of Testosterone Treatments Boosted by DTC Ad Campaigns

March 24, 2017 - Those with a stake in the pharmaceutical industry often question the effectiveness of direct-to-consumer (DTC) advertising, and whether it truly influences consumers to talk to their doctors about medical conditions and perhaps even ask for drugs by name.

Featured In: Pharmaceutical Marketing News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.